Target intelligence / Profile preview

Ribosomal ribonucleic acid (rRNA) (rRNA)

Target
rRNA
Molecular classification
Ribonucleic acid, Ribozyme, Non-coding RNA
01

Overview

Ribosomal RNA (rRNA) is the catalytic and structural component of the ribosome, the cellular machinery responsible for protein synthesis. In bacteria, the ribosome consists of the 30S and 50S subunits, containing the 16S, 23S, and 5S rRNA molecules, which serve as the primary targets for a wide range of clinically important antibiotics. These drugs bind to specific functional sites, such as the decoding center on the 16S rRNA or the peptidyl transferase center (PTC) on the 23S rRNA, to inhibit translation. Beyond these well-characterized pockets, 'additional ribosomal rRNA sites' refer to emerging or non-canonical binding regions being explored to overcome antibiotic resistance or to target eukaryotic rRNA in diseases like cancer. Because rRNA is highly conserved yet possesses distinct structural differences between prokaryotes and eukaryotes, it remains a cornerstone for selective toxicity in antimicrobial therapy.

Other names
Ribosomal RNA16S ribosomal RNA23S ribosomal RNA5S ribosomal RNA18S ribosomal RNA28S ribosomal RNA5.8S ribosomal RNARibosomal RNA binding sites
02

Mechanism of action

Inhibition of protein synthesis by binding to specific sites on the ribosomal RNA, leading to interference with decoding, translocation, or peptidyl transfer.

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activitymRNA decodingRibosome assembly
04

Disease associations

Bacterial infectionCancerRibosomopathyProtozoal infection
05

Safety considerations

Ototoxicity (e.g., aminoglycosides targeting mitochondrial rRNA)NephrotoxicityDevelopment of antibiotic resistanceDisruption of the human microbiome
06

Interacting drugs

Gentamicin

9 more in the full profile.

07

Biomarkers

rRNA mutations (e.g., A2058G in 23S rRNA for macrolide resistance)Methylation of rRNA (e.g., Erm methyltransferases)rRNA expression levels in cancer cells

Beyond the preview

Go deeper on Ribosomal ribonucleic acid (rRNA) (rRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal ribonucleic acid (rRNA) (rRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call